Cite

HARVARD Citation

    Takahashi, S. et al. (2021). Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer. Cancer science. 112 (4), pp. 1567-1578. [Online]. 
  
Back to record